1
Susan M Freier, Kenneth W Dobie, Sanjay Bhanot, Robert McKay: Modulation of glucagon receptor expression. ISIS Pharmaceuticals, Butzel Long, July 15, 2008: US07399853 (60 worldwide citation)

Compounds, compositions and methods are provided for modulating the expression of glucagon receptor. The compositions comprise oligonucleotides, targeted to nucleic acid encoding glucagon receptor. Methods of using these compounds for modulation of glucagon receptor expression and for diagnosis and ...


2
Susan M Freier: Modulation of glucagon receptor expression. Isis Pharmaceuticals, McDermott Will & Emery, July 6, 2010: US07750142 (11 worldwide citation)

Compounds, compositions and methods are provided for modulating the expression of glucagon receptor. The compositions comprise oligonucleotides, targeted to nucleic acid encoding glucagon receptor. Methods of using these compounds for modulation of glucagon receptor expression and for diagnosis and ...


3
Freier Susan M, Dobie Kenneth W, Mckay Robert: Modulation of glucagon receptor expression. Isis Pharmaceuticals, Freier Susan M, Dobie Kenneth W, Mckay Robert, BRUSCA Eric M, November 11, 2004: WO/2004/096016 (10 worldwide citation)

Compounds, compositions and methods are provided for modulating the expression of glucagon receptor. The compositions comprise oligonucleotides, targeted to nucleic acid encoding glucagon receptor. Methods of using these compounds for modulation of glucagon receptor expression and for diagnosis and ...


4
Freier Susan M: Modulation of glucagon receptor expression. Isis Pharmaceuticals, Freier Susan M, BRUSCA Eric M, November 11, 2004: WO/2004/096996 (9 worldwide citation)

Compounds, compositions and methods are provided for modulating the expression of glucagon receptor. The compositions comprise oligonucleotides, targeted to nucleic acid encoding glucagon receptor. Methods of using these compounds for modulation of glucagon receptor expression and for diagnosis and ...


5
Monia Brett P, Freier Susan M, Bhanot Sanjay: Modulation of glucagon receptor expression. Johnson & Johnson Pharmaceutical Research & Development, Monia Brett P, Freier Susan M, Bhanot Sanjay, KURLANDSKY David R, March 29, 2007: WO/2007/035771 (9 worldwide citation)

Compounds, compositions and methods are provided for modulating the expression of glucagon receptor. The compositions comprise antisense compounds, particularly antisense oligonucleotides which have particular in vivo properties, targeted to nucleic acids encoding glucagon receptor. Methods of using ...


6
Sanjay Bhanot, Lynnetta Watts, Robert McKay, Susan M Freier: Modulation of glucagon receptor expression. Isis Pharmaceuticals, Isis Pharmaceuticals Patent Dept, April 5, 2011: US07919476 (2 worldwide citation)

Compounds, compositions and methods are provided for modulating the expression of glucagon receptor. The compositions comprise oligonucleotides, targeted to nucleic acid encoding glucagon receptor. Methods of using these compounds for modulation of glucagon receptor expression and for diagnosis and ...


7
Susan M Freier, Kenneth W Dobie, Robert McKay, Sanjay Bhanot: Modulation of glucagon receptor expression. Isis Pharmaceuticals, Isis Pharmaceuticals Patent Dept, February 4, 2014: US08642753 (1 worldwide citation)

Compounds, compositions and methods are provided for modulating the expression of glucagon receptor. The compositions comprise oligonucleotides, targeted to nucleic acid encoding glucagon receptor. Methods of using these compounds for modulation of glucagon receptor expression and for diagnosis and ...


8
MONIA BRETT P, FREIER SUSAN M, BHANOT SANJAY: Modulation of glucagon receptor expression, Modulation der Glucagonrezeptorexpression, Modulation dexpression de récepteur de glucagon. ISIS PHARMACEUTICALS, November 23, 2011: EP2388326-A1

Compounds, compositions and methods are provided for modulating the expression of glucagon receptor. The compositions comprise antisense compounds, particularly antisense oligonucleotides which have particular in vivo properties, targeted to nucleic acids encoding glucagon receptor. Methods of using ...


9
MONIA BRETT P, FREIER SUSAN M, BHANOT SANJAY: [fr] Modulation dexpression de récepteur de glucagon, [de] Modulation der Glucagonrezeptorexpression, [en] Modulation of glucagon receptor expression. JOHNSON & JOHNSON PHARMACEUTIC, September 2, 2009: EP2096170-A1

[en] Compounds, compositions and methods are provided for modulating the expression of glucagon receptor. The compositions comprise antisense compounds, particularly antisense oligonucleotides which have particular in vivo properties, targeted to nucleic acids encoding glucagon receptor. Methods of ...


10